Open AccessThe level of antibodies to Chlamydia pneumoniae and Mycoplasma pneumoniae among patients with bronchial asthma
Author(s) -
R. F. Khamitov,
В Г Новоженов,
I. G. Mustafin,
V. A. Sergeev,
R. M. Kharrasova,
N. Sh. Mansurova,
T. N. Sulbaeva,
L. Yu. Palmova,
I. Yu. Bogorodskaya
Publication year - 2022
Publication title -
kazanskij medicinskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2587-9359
pISSN - 0368-4814
DOI - 10.17816/kazmj96293
Subject(s) - mycoplasma pneumoniae , antibody , chlamydia , asthma , immunology , chlamydophila pneumoniae , medicine , chlamydiaceae , titer , immunofluorescence , chlamydiales , pneumonia
The level of antibodies to chlamydia pneumoniae (Cp) and Micoplasma pneumoniae (Mp) in 65 patients with bronchial asthma in the clinical remission phase is studied. To reveal antibodies to Cp the indirect immunofluorescence reaction was used, to reveal antibodies to Mp the indirect immunoenzymic analysis method was used. In diagnostic titer the antibodies to Cp were found in 23 patients and antibodies to Mp were found in 25 patients (38%) of 65. In 6 (9,2%) of them the antibodies to Cp were also determined. In patients of seropositive and seronegative groups the differences on some anamnestic and laboratory data, accompanying somatic pathology in medical complex were revealed. |